BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8785709)

  • 1. Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression.
    Zhang JF; Hu C; Geng Y; Blatt LM; Taylor MW
    Cancer Gene Ther; 1996; 3(1):31-8. PubMed ID: 8785709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy against an experimental glioma using adeno-associated virus vectors.
    Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
    Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
    Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
    Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
    J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
    Hiroishi K; Tüting T; Tahara H; Lotze MT
    Gene Ther; 1999 Dec; 6(12):1988-94. PubMed ID: 10637450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
    Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
    Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
    Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
    Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
    Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
    Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
    Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
    Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H; Lu R; Ding R; Kan YW
    Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide gene therapy of sarcoma cell lines using recombinant adeno-associated virus 2 vectors.
    Veldwijk MR; Berlinghoff S; Laufs S; Hengge UR; Zeller WJ; Wenz F; Fruehauf S
    Cancer Gene Ther; 2004 Aug; 11(8):577-84. PubMed ID: 15280909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
    Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ
    Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.
    Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M
    Cancer Gene Ther; 2004 Jan; 11(1):73-80. PubMed ID: 14681728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.
    Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C
    Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor activity of the human consensus type I interferon gene.
    Geng Y; Yu D; Blatt LM; Taylor MW
    Cytokines Mol Ther; 1995 Dec; 1(4):289-300. PubMed ID: 9384682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.